The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease by Craddock, Travis J. A. et al.
The Zinc Dyshomeostasis Hypothesis of Alzheimer’s Disease
Travis J. A. Craddock
1*, Jack A. Tuszynski
1,2, Deepak Chopra
3, Noel Casey
4, Lee E. Goldstein
4,
Stuart R. Hameroff
5, Rudolph E. Tanzi
6
1Department of Physics, University of Alberta, Edmonton, Alberta, Canada, 2Division of Experimental Oncology, Cross Cancer Institute, University of Alberta, Edmonton,
Alberta, Canada, 3The Chopra Center for Well-Being, Carlsbad, California, United States of America, 4Center for Biometals & Metallomics, Alzheimer’s Disease Center,
Boston University School of Medicine, Boston, Massachusetts, United States of America, 5Departments of Anesthesiology and Psychology, Center for Consciousness
Studies The University of Arizona Health Sciences Center, Tucson, Arizona, United States of America, 6Genetics and Aging Research Unit, Department of Neurology,
Massachusetts General Hospital- East, Charlestown, Massachusetts, United States of America
Abstract
Alzheimer’s disease (AD) is the most common form of dementia in the elderly. Hallmark AD neuropathology includes
extracellular amyloid plaques composed largely of the amyloid-b protein (Ab), intracellular neurofibrillary tangles (NFTs)
composed of hyper-phosphorylated microtubule-associated protein tau (MAP-tau), and microtubule destabilization. Early-
onset autosomal dominant AD genes are associated with excessive Ab accumulation, however cognitive impairment best
correlates with NFTs and disrupted microtubules. The mechanisms linking Ab and NFT pathologies in AD are unknown.
Here, we propose that sequestration of zinc by Ab-amyloid deposits (Ab oligomers and plaques) not only drives Ab
aggregation, but also disrupts zinc homeostasis in zinc-enriched brain regions important for memory and vulnerable to AD
pathology, resulting in intra-neuronal zinc levels, which are either too low, or excessively high. To evaluate this hypothesis,
we 1) used molecular modeling of zinc binding to the microtubule component protein tubulin, identifying specific, high-
affinity zinc binding sites that influence side-to-side tubulin interaction, the sensitive link in microtubule polymerization and
stability. We also 2) performed kinetic modeling showing zinc distribution in extra-neuronal Ab deposits can reduce intra-
neuronal zinc binding to microtubules, destabilizing microtubules. Finally, we 3) used metallomic imaging mass
spectrometry (MIMS) to show anatomically-localized and age-dependent zinc dyshomeostasis in specific brain regions of
Tg2576 transgenic, mice, a model for AD. We found excess zinc in brain regions associated with memory processing and
NFT pathology. Overall, we present a theoretical framework and support for a new theory of AD linking extra-neuronal Ab
amyloid to intra-neuronal NFTs and cognitive dysfunction. The connection, we propose, is based on b-amyloid-induced
alterations in zinc ion concentration inside neurons affecting stability of polymerized microtubules, their binding to MAP-
tau, and molecular dynamics involved in cognition. Further, our theory supports novel AD therapeutic strategies targeting
intra-neuronal zinc homeostasis and microtubule dynamics to prevent neurodegeneration and cognitive decline.
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Introduction
Alzheimer’s disease (AD) is the major cause of dementia and a
leading cause of death in the elderly. Early symptoms include
inability to form new memories, confusion, and mood swings.
Clinical progression inevitably involves cognitive dysfunction,
neuropsychiatric disturbances, psychosocial derailment, and
death. Although numerous therapeutic approaches have been
implemented, no clinically useful disease-modifying treatments are
currently available. With tens of millions of AD patients worldwide
requiring care and accelerating AD epidemiological trends, the
disease presents medical, social and economic problems of global
proportion.
The brains of patients affected by AD have two types of
neuropathological lesions. In AD, extracellular deposition of the
,4 kDa amyloid-b (Ab) peptide derived from the amyloid
precursor protein (APP), leads to amyloid plaques and neurotoxic
oligomers that impair long term potentiation (LTP) and synaptic
function [1]. At the intracellular level, cortical neurons in the AD
brain accumulate hyper-phosphorylated tau, a microtubule-
associated protein (MAP), which triggers formation of neurofibril-
lary tangles (NFTs) [1]. Neurons in AD brain also demonstrate
impaired axonal transport, motor protein transport along axonal
microtubules (MTs), and compromised MT networks [2].
While all four established AD genes lead to excessive
accumulation of Ab peptide in the brain, resulting b-amyloid
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Dementia and neurodegeneration initiated by b-amyloid deposi-
tion require tauopathy and microtubule destabilization, including
NFT formation [3]. How b-amyloid accumulation in AD brain
leads to NFT pathology remains unknown. Zinc has previously
been shown to promote the aggregation of b-amyloid, which
sequesters the metal and promotes local zinc dyshomeostasis in the
vicinity of b-amyloid deposits [4]. Here we argue that Ab-
mediated zinc sequestration outside neurons depletes intra-
neuronal zinc stores leading to MT destabilization, NFT
formation, and neuronal degeneration, neuronal degeneration.
Ab aggregation may also result in excessive intra-neuronal levels of
zinc. In this model of AD, MT destabilization is the primary cause
of tau release and hyperphosphorylation, NFT formation,
neuronal dysfunction, and dementia.
In this article we first review the role and relevance of neuronal
microtubules to memory and cognitive functions affected by AD.
We then report on three approaches we employed to test our
hypothesis of a zinc connection between b-amyloid, microtubules
and AD pathology.
1) Using molecular modeling of tubulin, the component protein
of MTs, we identified specific, high-affinity electrostatic zinc
binding sites that influence side-to-side tubulin interaction,
the sensitive link in microtubule polymerization and lattice
stability. This suggests that insufficient levels of intraneuronal
zinc would destabilize MTs, free tau proteins, and disrupt
intra-neuronal cytoskeletal architecture, thereby impairing
memory and cognition. Additionally, we show how excessive
intra-neuronal zinc can disrupt MT polymerization through
aberrant tubulin-tubulin binding.
2) We performed kinetic modeling showing zinc distribution in
extra-neuronal Ab deposits can cause intra-neuronal zinc
depletion, reduced zinc binding to microtubules, and
microtubule disruption.
3) We used metallomic imaging mass spectrometry (MIMS) to
show anatomically-localized and age-dependent zinc dysho-
meostasis in specific brain regions of Tg2576 transgenic, AD-
model mice, brain regions (e.g. hippocampus, dentate gyrus,
subiculum, and cortical layer II) associated with memory,
cognition and NFT pathology.
We present a comprehensive theory of AD pathogenesis in
which b-amyloid plaque formation promotes intra-neuronal zinc
depletion, and/or excess intra-neuronal zinc, to levels, which
disrupt MTs, promote NFTs, and promote cognitive impairment.
This in turn suggests novel AD therapeutic strategies aimed at
restoring intraneuronal zinc homeostasis and stabilizing microtu-
bule lattice structure.
Microtubules and Memory
Cytoskeletal polymers including actin, neurofilaments and MTs
structurally and dynamically organize the interiors of neurons, and
other cells. The most rigid cytoskeletal component, MTs self-
assemble from tubulin proteins to form microns-long hollow
cylinders with outer diameters of 25–26 nm and inner diameters
of 15 nm. MTs typically consist of 13 linear chains of tubulin
dimers called protofilaments, which align side-to-side resulting in
hexagonal lattices of tubulin dimers comprising the MT cylindrical
wall. MTs have an electric and functional polarity. MT assembly
and subsequent binding of various MAPs determine cell form and
function, including formation and maintenance of neuronal axons,
dendrites and synapses.
Tubulin is a heterodimer consisting of 55 kD a-tubulin and b-
tubulin monomers (see Fig. 1), highly conserved in eukaryotic cells.
Tubulin polymerization depends on various physical (temperature)
and chemical (pH, concentration of ions) factors. Under normal
conditions, tubulin assembly depends on GTP occupancy. Each
tubulin dimer can bind two guanosine-tri-phosphate (GTP) one at
a non-exchangeable site on the alpha monomer, another at an
exchangeable site on the beta monomer at which GTP can
hydrolyze to guanosine-di-phosphate (GDP), imparting energy
and conformational flexing to the underlying tubulin. In
assembling MTs, exchangeable GTP tubulin on the exposed end
will undergo hydrolysis within a brief time if not covered by
another tubulin. Thus MTs, which continue to grow and add GTP
tubulin, are stable. However if assembly stalls, GTP hydrolysis at
the MT exposed end occurs, and triggers rapid disassembly
(termed MT ‘catastrophes’) (Figure 1).
Usually, assembly proceeds by formation of protofilaments,
which then align side-to-side, and disassembly occurs via
separation of side-to-side protofilaments. Because GTP hydrolysis
to GDP causes conformational flexing of the tubulin dimer,
Figure 1. Microtubule assembly/disassembly. Each longitudinal protofilament of an MT is made up of a and b tubulin subunit heterodimers.
Assembly of MTs depends on addition of ‘GTP-tubulin’. Top, right: blue dimers with both exchangeable and non-exchangeable sites occupied by GTP
will continue to add to assembling MTs. Bottom, right: dimers at MT edge which hydrolyze GTP to GDP flex and separate protofilaments from MT,
curved protofilaments resembling ‘rams horns’.
doi:10.1371/journal.pone.0033552.g001
The Zinc Dyshomeostasis Hypothesis of AD
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33552protofilaments separate and curve away from one another in a
pattern referred to as ‘‘ram’s horns’’ (Figure 1). In many cells and
conditions, MTs exist in cycles of assembly/disassembly called
‘dynamic instability’, useful in probing and retreating in cell
growth and development. Some MTs assemble at one end and
disassemble at the other, a process called ‘treadmilling’. However
in brain neurons, specialized MAPs called ‘STOP’ proteins cap
MT ends, preventing GTP hydrolysis, dynamic instability and
treadmilling. MTs in brain neurons are stable, and potential sites
for memory and cognitive processes in normal healthy conditions.
However abnormal physiological or biochemical conditions can
affect MT assembly, e.g. resulting in aberrant formation of closely
or widely spaced MTs, tubulin sheets, rings/ribbons or various
other structures [5–7], (Figure 2). One important factor among
these is zinc ion concentration. Whereas low/moderate levels of
zinc enhance tubulin polymerization, excessive zinc levels induce
tubulin to form flat sheets rather than cylinders (Figure 2B).
In all eukaryotic cells, MTs and cytoskeletal components
establish cell shape and enact movement, including mitosis,
growth and motility, by their own assembly and coordinated
activities of MAPs and actin filaments. In highly asymmetrical
neurons, microtubules play an especially important role in cell
morphology; establishing and maintaining elongated axons,
dendrites and their synapses. In neuronal axons, MTs are
continuous and of the same polarity, while in dendrites MTs are
interrupted and of mixed polarity. In both axons and dendrites,
various MAPs interconnect MTs into networks, scaffolding of the
neuronal and synaptic architecture. Once formed, synapses are
regulated by transport of synaptic components along MTs by
motor proteins kinesin and dynein. Material synthesized in the cell
body may require transport through a highly branched dendritic
tree, switching from MT to MT numerous times. The motor
protein mechanical transport requires chemical energy (ATP
hydrolysis), but the guidance mechanism, which brings specific
precursors to regulate specific synapses, is unknown. Recently tau,
the MAP involved in AD, was shown to act as a traffic signal,
discharging motor proteins and their cargo at specific locations on
the MT lattice network [8]. Thus, specific binding sites and
patterns of tau (and other MAPs) on MT lattices can encode
information involved in synaptic plasticity, i.e. memory.
Memory is generally considered to depend on synaptic
plasticity, sensitivity of specific synapses in neuronal networks,
guiding network activity and computation. However, synaptic
proteins and other components last only hours to days, being
recycled by materials transported by motor proteins along
microtubules. Another site for memory encoding and storage is
required. Several lines of evidence point to microtubules.
Cronly-Dillon and co-workers [9] showed that when baby rats
first open their eyes, genes in visual cortex suddenly begin
producing vast quantities of tubulin. When the rats are 35 days
old, the critical phase for learning is over and tubulin production is
drastically reduced. They concluded tubulin turnover and
microtubule activity are involved in synaptic plasticity, learning
and memory.
Dendrite-specific MAP2 is particularly important in memory
consolidation, with reduced levels or activity in situations of
impaired memory. For example memory deficits correlate with
decreased levels of MAP2 in hippocampus [10–12], and cerebral
hypoperfusion with impaired cognitive performance results in
decreased MAP2 [13]. The senescence-accelerated (SAMP10)
mouse strain, which exhibits learning and memory deficits,
expressed less cortical MAP2 [14]. Transgenic mice with altered
MAP2 showed impairments of contextual memory and reduced
capacity for phosphorylation of MAP2 [15].
Increased learning correlates with enhanced MAP2 activity.
Fear conditioning produced clear changes in MAP2 immunohis-
tochemical staining in regions of the cerebral cortex or
hippocampus [16–18]. Enhanced MAP2 turnover [19] was found
in pyramidal cells of the hippocampus with contextual learning.
Similar learning-related changes in MAP2 followed avoidance
training [20]. MAP2-mediated reorganization of MT networks
correlates with memory.
Memory and learning are studied through in vivo models of
‘long-term potentiation’ (LTP), e.g. in hippocampal slice. Induced
high frequency pre-synaptic stimulation results in prolonged,
enhanced post-synaptic sensitivity, presumably correlating with
Hebbian learning in synapses. During LTP, MAP1B phosphor-
ylation [21] and local concentrations of mRNA for MAP2 and for
Ca
2+-calmodulin-dependent kinase II (CaMKII) increase [22].
CaMKII is responsible for phosphorylating MAP2, enhancing
synaptic response [23].
A key step in LTP occurs when calcium ions enter the post-
synaptic neuron and activate the hexagonal holoenzyme CaMKII,
causing it to transform and extend 6 kinase domains above and
below the main body. These kinase domains can phosphorylate
intra-neuronal targets for memory encoding and storage. Hamer-
off et al [24,25] showed that the geometry of 6 extended CaMKII
kinase precisely matches microtubule lattices, enabling CaMKII to
phosphorylate 6 bits of information (one byte) to a small region of
a MT lattice. Previous theoretical work had suggested various
forms of information processing in microtubules [26–28]. MT-
depolymerizing agents cause amnesia, and LTP with protein
synthesis involves formation of new MT tracks between stimulated
synapses and the nucleus in the soma. MTs are likely candidates
for memory storage. Tubulin is a candidate to manifest interactive
bit-like information states.
Generally considered as merely bone-like structural support,
MTs have been proposed to also function as intra-cellular
information processing devices in which tubulin states represent
and process fundamental information bits (by phosphorylation,
conformation, dipoles) within MT lattices acting as computational
automata [29–31]. Individual tubulin states within MT lattices
may be further modified/programmed not only by phosphoryla-
tion, but also by post-translational modifications and binding of
various ligands and MT-associated proteins. Such information
could also be transferred to particularly long-lasting and stable
parallel cytoskeletal structures including neurofilaments, and read
out, or implemented in several ways. Post-synaptic dendritic/
Figure 2. Tubulin assembly depends on ambient conditions. (A)
Cylindrical ‘B-lattice’ MT composed of 13 protofilaments, formed under
physiological conditions. (B) In excess zinc ion concentration, tubulin
forms flat sheets rather than cylinders. (C) Tubulin can form double
protofilaments and other types of assemblies described in [7].
doi:10.1371/journal.pone.0033552.g002
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determine axonal firing as outputs, and also regulating synaptic
plasticity. Specific patterns of phosphorylation would likely modify
and influence dynamical MT functions governing neurite
extension, motor protein transport and binding sites for MT-
associated proteins determining synaptic architecture and plastic-
ity. MTs are logical sites for intra-neuronal memory processing.
MAPs, Tau, Neurofibrillary Tangles and Alzheimer’s
Disease
Intraneuronal pathological lesions in AD involve hyper-
phosphorylated tau which first oligomerizes, then forms insoluble
paired-helical filaments (PHFs) and finally NFTs, which also may
include MAP-2. Concomitant with PHF and NFT formation,
MTs also depolymerize. The sequence of these events remains
uncertain.
MAP-tau is one of many microtubule-associated proteins in
brain neurons (Table 1). At the neuronal cellular level, MTs in
neuronal cell body/soma and dendrites bind MAP2 preferentially,
whereas MTs in axons prefer MAP-tau. Nevertheless, hyper-
phosphorylated MAP-tau, PHFs and NFTs are highly concen-
trated in the somato-dendritic part of the neuron, with relative
sparing of axons.
Woolf et al. suggested an imbalance of MAPs throughout brain
neurons lead to cytoskeletal breakdown in AD [32]. MAP-tau
over-expression in hippocampal neurons results in increased
MAP-tau levels in dendrites and loss of dendritic spines [33],
suggesting that MAP-tau competes with other MAPs affecting MT
dynamics. In the AD brain, expression of MAP2 (found primarily
in dendrites and implicated in learning and memory) is decreased
while MAP-tau levels remain normal [34], and MAP2 immuno-
staining is negatively correlated with NFT levels [35]. These
results suggest an inverse relationship between MAP2 levels and
the presence of NFTs. NFTs and associated MT depolymerization
in soma and dendrites are most debilitating to neuronal function,
consistent with other approaches suggesting cognition, memory
and consciousness occur primarily in soma and dendrites rather
than in axonal firings [36].
Prior to displacement from MTs, MAP-tau is linear, approx-
imately 16 nanometers in length, contacting and extending over
two or more dimers along a protofilament (Figure 3). Functionally,
MAP-tau has been thought to stabilize MTs, but, as mentioned
above, recent evidence suggests that tau acts like a motor-protein
traffic signal, causing the release of synaptic cargo and regulating
synaptic plasticity [8] This implies tau-binding locations are
encoded as information in MT lattices.
Current dogma suggests MAP-tau is hyper-phosphorylated on
MTs, leading to MT destabilization and aggregation of MAP-tau
(and other MAPs) into insoluble protein clusters. The tau protein
then coils into paired helical filaments (PHFs), which adopt a b-
conformation, eventually transforming the aggregate into NFTs
(Figure 3). But evidence is inconsistent, and molecular events
triggering NFT formation remain unclear.
Thus the following are open questions. Does hyperphosphor-
ylation of MAP-tau on MTs lead to MT disruption, removal of
MAP-tau from MTs, and NFTs? Or does MT depolymerization
initiate the process, causing release of MAP-tau, which is then
hyper-phosphorylated to form NFTs? Which of these cause
cognitive defects? How can they be stopped?
Hyper-phosphorylated MAP-tau and NFTs separated from
MTs can dramatically alter MT dynamics, for example blocking
MT assembly. In experiments where hyper-phosphorylated MAP-
tau isolated from Alzheimer’s disease brain is added to mouse
embryonic fibroblasts, MT polymerizations is impaired, suggesting
that MAP-tau hyper-phosphorylation is responsible for the MT
dysfunction in AD.
However NFTs and hyper-phosphorylated tau may exacerbate
MT defects already present in AD patients’ brains. Some studies
indicate MT dysfunction is a primary problem in AD, and not
merely a result of NFTs compromising neuronal integrity [2].
When neurons in AD brain were evaluated for MT abnormalities,
Table 1. Microtubule-binding proteins and their functions.
Protein Functions References
Stabilizing MAPs
MAP1A Neural development; stabilization of MTs in axons and dendrites [105,106]
MAP1B Neural development; stabilization of MTs in axons and dendrites [105–108]
MAP2A Neural development; stabilization of MTs in dendrites; signal transduction [105,109–110]
MAP2B Neural development; stabilization of MTs in dendrites, signal transduction [105 109–110]
MAP2C Early neural development [105,109–111]
MAP-tau Neural development; stabilization of MTs in axons; axonal transport [105,109,111]
Proteins related to specific neurodevelopmental disorders
ASPM
* Responsible for brain enlargement [112]
DCX
** Neural development; cortical neuron migration [112]
LIS1
{ Neural development; cortical neuron migration [112]
CLIP-115
{{ Regulates MT dynamics by binding to tips of growing MTs [113]
Motor proteins
Dynein Retrograde transport in the axon; transport to minus ends of MTs in dendrites [114,115]
Kinesin Anterograde transport in the axon; transport to plus ends of MTs in dendrites [114,115]
*ASPM: abnormal spindle-like protein, microencephaly-associated.
**DCX: doublecortin.
{LIS1: lissencephaly-1.
{{CLIP-115: cytoplasmic linker protein-115.
doi:10.1371/journal.pone.0033552.t001
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AD brains exhibited MT defects, with MT numbers and total MT
lengths decreased compared to those in neurons from controls.
Neurons in AD brains also demonstrate impaired motor protein
transport along MTs, and compromised MT-MAP networks [2].
Recent evidence suggests that preventing neurofibrillary tangles is
more likely to protect against dementia and cognitive impairment
than is targeting b-amyloid plaques [3].
Here, we assess whether the primary event driving NFT
formation is MT instability due to reduced zinc concentration in
neuronal cytoplasm. We examine in detail the theoretical binding
sites for zinc on tubulin, the constituent protein of microtubules.
Tubulin, Zinc, and Microtubule Polymerization
MTs are polymers of tubulin. The atomic structure of tubulin
was resolved to within 3.7 A ˚ resolution from electron crystallog-
raphy by Nogales et al [37], and later refined [38] to 3.5 A ˚.
Tubulin has a b- sheet core, surrounded by a-helices and a
Rossmann-fold nucleotide-binding domain at the N-terminal
region. It also has an intermediate domain containing a mixed,
four-strand b sheet and three helices. A third domain consists of
two anti-parallel helices that cross the first two domains.
As shown in Figure 4, the tubulin C-terminus, known as the C-
terminal ‘tail’, extends outward from the MT surface on each
monomer with significant negative electric charge (as much as 40%
of the total monomer charge). These negative charges on each C-
terminus are responsible for its extended conformational state since
the surface charge is also negative leading to Coulomb repulsion.
Electric charge distribution is crucial to the organization of tubulin
dimersintoaMTlatticeascanbeseeninFigure4forthea-bdimers.
Zinc is an abundant transition metal found in large concentra-
tions in mammalian brain with some synapses in the hippocampus
containing concentrations as high as 150 mM. Of this, 85–90% is
bound to zinc metalloproteins, the remaining 10–15% either loosely
bound or free in presynaptic vesicles [39–41]. Cytosolic free
concentration of zinc in cultured neurons is generally subnanomo-
lar, however in pathological conditions levels of free zinc ion (Zn
2+)
can change via several pathways [42]. Free zinc is a potent killer of
neurons and glia with extended exposure to as little as 100 nM
leading to neuronal death [42]. However critical amounts of bound
zinc are essential for various enzymes and biochemical activities.
Zinc binds to tubulin and affects its polymerization into MTs
[43,44]. For low zinc to tubulin ratios, polymerization of tubulin
into MTs is enhanced both in vitro and in vivo. However at zinc to
tubulin ratios exceeding 3:1, tubulin polymerization becomes
aberrant, forming flat sheets rather than cylinders [45–48]. This
suggests the tubulin dimer optimally binds 1 to 3 zinc ions.
Axons incubated with low zinc concentrations (5 mM) show
increased motor protein transport along microtubules; cultured
neurons incubated in high zinc concentrations (0.1–1.0 mM) have
structural damage and decreased motor protein activity along MTs
[49–51]. Dietary zinc deficiencyresults in the impairment of tubulin
polymerization into MTs [52–54]. It appears MTs function
optimally at an intermediate range, a window of zinc concentration.
Zinc deficiency may also lower levels of a- and b-tubulin, MAP2
expression and impair MT polymerization [55,56]. Zinc deficien-
cy effects on lowered MT polymerization rates are apparently
mediated through decreased electrostatic attraction between
tubulin dimers, as well as decreased expression of MAP-tau,
MAP2, and potential lowering of MAP-tau binding to MTs. We
focus on zinc binding to tubulin.
In equilibrium conditions, Eagle et al. [57] found 65 zinc binding
sites on tubulin for zinc, 10 of which were so-called high affinity sites
with Kd ,2.6 mM, and 55 were low affinity sites with Kd ,55 mM.
Under assembly conditions 3 sites of Kd ,0.9 mMa n d1 7s i t e sK d
,16 mM were found. However, Hesketh found zinc-binding sites
with 110 mM [58]. The location of these sites remains unknown. The
only identified zinc-tubulin binding site is the putative sheet-inducing
site from the tubulin crystal structure [37,38]. GTP concentration
affects zinc binding [57], and the exchangeable GTP site on tubulin is
altered by zinc [59]. Bound zinc ions also alter the colchicine-binding
site on tubulin [60], and zinc may alter tubulin phosphorylation [61].
Methods
Molecular Modeling of Theoretical Zinc Binding Sites on
Tubulin
Tubulin and MT Modeling. The Protein Data Bank (PDB)
[62] crystal structure of bovine brain tubulin 1JFF [38] was
repaired via homology modeling by adding missing residues from
1TUB [37] using MODELLER 9V6 [63]. The repaired 1JFF
dimer was solvated, neutralized and energy-minimized using the
molecular dynamics simulator NAMD [64], developed by the
Theoretical and Computational Biophysics Group in the Beckman
Institute for Advanced Science and Technology at the University
of Illinois at Urbana-Champaign. Using this dimer, MT A and B
lattice structures were built with PYMOL 0.99rc6 [65] using MT
geometry described in Li et al. [66] and Sept et al. [67].
Figure 3. Schematic illustration of MT depolymerization in AD neurons. (A) Microtubule stabilized by MAP-tau (red). (B) Destabilized
microtubule and free MAP-tau with additional phosphorous (yellow). (C) Neurofibrillary tangles formed of hyper-phosphorylated MAP-tau.
doi:10.1371/journal.pone.0033552.g003
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zinc-binding sites on tubulin the minimized repaired 1JFF
structure was run through the robust zinc protein-binding site
prediction algorithm FEATURE: Metals [68] FEATURE: Metals
structurally predicts zinc-binding sites based on coordination
geometry trained on positive (known zinc binding sites) and
negative (non-metal binding regions with characteristics of zinc
binding sites) samples in conjunction with additional biophysical and
biochemical properties averaged around the site of interest, with a
73.6% in unbound known proteins structures and 65.5% in protein
structures determined from homology models. Low stringency
results were spatially clustered via a density-based spatial clustering
of applications with noise (DBSCAN) [69] with a minimum group
size of 1 and a nearest-neighbor distance of 1.5 A ˚.
Electrostatic Analysis. To analyze the electrostatics of the
systems, hydrogens were added, and protonation states set at pH 7
with PROPKA [70], via PDB2PQR [71,72] for both the tubulin
dimer and MT lattice structures. The Poisson-Boltzmann equation
was solved for the structures in given arrangement with the
Adaptive Poisson-Boltzmann Solver (APBS) [73] with less than
1A ˚ spacing. To investigate the effect of the zinc ions of the
electrostatic profile of tubulin the Poisson-Boltzmann equation was
solved for the tubulin dimer both with zinc ions, at the top six sites.
Zinc ions were given a charge of +2e and radius of 1.10 A ˚.
Charges on the key binding residues were modified to allow zinc
binding, partially canceling the zinc charge following the cationic
dummy atom approach (CaDA) [74–76]: Cysteine and histidine
residues were used in their anionic form, and glutamic acid and
aspartic acid were used in their neutral form.
All illustrations were created using PYMOL 0.99rc6 [65].
Metallomic Imaging Mass Spectrometry (MIMS Mapping)
of Elemental Zinc Distribution in the Brain of Aged Tg2576
AD Transgenic Mice Compared to Wild Type Controls
Analysis of murine brain specimens by MIMS was conducted at
the Center for Biometals and Metallomics, Boston University
School of Medicine, Boston, MA, USA. A double-focusing
Figure 4. Charge distribution on the surface of an MT following [72]. Red – negative charge at a potential of
21 kT/e, Blue – positive charge
at a potential of 1 kT/e. (A) Close up, a single tubulin dimer electrostatic map. (B) Close up, Electrostatic attraction between tubulin dimers during MT
polymerization. (C) Microtubule polymerization. (D) Opposing faces of adjacent dimers showing complimentary electrostatic patterns.
doi:10.1371/journal.pone.0033552.g004
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Waltham, MA, USA) was custom hyphenated to a Nd-YAG laser
with frequency quadrupling to attain 213 nm output(LSX 213,
Cetac Technologies, Omaha, NE, USA). Laser pulse duration was
5 ns with a maximum pulse frequency of 20 Hz. Energy density
was constant at a maximum of 4 mJ. Spot size was varied between
5 mm (high resolution) and 50 mm (low resolution). Laser-generated
aerosol was transported from a custom-designed laminar flow
cryogenically-cooled laser ablation cell (Geomed Analytical,
University of Massachusetts, MA, USA) maintained at 215 to
225uC 60.1uC to the sector field ICP mass spectrometer by a
carrier gasmixture of heliumandargon atconstant flow rates of1 L
min
21 and 0.8 L min
21, respectively. The ICP-mass spectrometer
was synchronized with the laser ablation platform using an external
contact closure trigger. Ions generated in the ICP were extracted
into the mass spectrometer and separated according to mass-to-
charge ratio. The ICP torch was shielded with a grounded platinum
guard electrode. ICP-mass spectrometer analytical optimization
and calibration was performed using
59Co,
139La, and
232Th line-
scanning ablation of a reference glass standard (SRM 612, National
Institute of Standards and Technology, Gaithersburg, MD, USA).
Analytical conditionswereoptimized to ensure that oxide formation
was,1% based on ratio measurement of
232Th
16O and
232Th.The
hyphenated laser ablation-assisted MIMS system generated a signal
of ,7% RSD for a 2 min continuous line scan at a spot size of
50 mm, line scan velocity of 50 mm/s, and frequency of 20 Hz. The
plasma conditions for MIMS analysis of brain specimens were
optimized for
63Cu,
66Zn and
70Zn. Brain specimen positioning was
accomplished by coordination with a multi-line map grid with
50 mm spacing between adjacent lines. After MIMS analysis, data
sets were exported to customized Matlab program (Matlab 2010,
Mathworks, MA, USA) for raw data processing, analytical
quantitation, and two-dimensional mapping. Color intensity image
maps were produced for each isotope by converting the temporally
acquired sector field ICP-mass spectrometry signal (counts/second)
into distance (microns) travelled by the laser ablation platform.
We deployed high resolution MIMS mapping to test the
hypothesis that increased AD-linked Ab accumulation in aged
Tg2576 AD transgenic mice is associated with local zinc
dyshomeostasis in zinc-enriched brain regions affected by AD
neuropathology. To conduct this study, we used aged Tg2576 AD
transgenic mice [77] that carry a transgene construct containing
the human Swedish mutant APP (APPswe).
This study was approved following full board review by the
Boston University School of Medicine Institutional Animal Care &
Use Committee (IACUC) and approved as protocol AN-
15088.2011.03 effective 6/09/2011 (expiration 3/18/2012).
Results
Theoretical zinc binding sites on tubulin
Under low stringency the zinc prediction program yields 591
non-unique hits. Clustering these by spatial density [69] reveals 64
unique zinc sites, however 6 of them are on the C-terminal tails
and, due to their flexibility and high sequence variability between
isoforms, cannot be taken as definitive. This leaves 58 predicted
sites in agreement with the results of Eagle et al. [57]. Of the 58
predicted, one is at the exchangeable GTP site, 4 at the non-
exchangeable GTP site, one at the colchicine site, 2 at the taxol
site, and 3 are within 3 A ˚ of SER and THR residues which may be
phosphorylated in the C-terminal region [78]. Additionally, two of
the residues in the putative zinc site given by the zinc-induced
sheet crystal structure [38] are also predicted. Under the highest
stringency, only 6 sites are predicted, and these include the
colchicine-binding site, the exchangeable GTP/GDP site, and one
residue given in the putative zinc-induced sheet site (see Figure 5).
Cysteine, histidine, aspartic acid and glutamic acid amino acid
residues account for ,97% of all zinc-binding amino acids [79].
Typically, four of these residues are capable of neutralizing the
charge of the zinc ion, binding it in place. However, the amino
acid residues surrounding the predicted zinc sites on a single
tubulin dimer do not contain enough of these key residues to
stabilize the zinc ion. Hydroxide ions in water are capable of
reacting with zinc, potentially stabilizing zinc at the predicted sites.
Another possibility is that unbalanced charge of zinc at these sites
plays a role in electrostatic protein-protein interactions, namely
MT polymerization.
The electrostatic profile of the tubulin dimer is critical to MT
polymerization dynamics. While the overall surface charge density
of tubulin is negative, key regions along the longitudinal dimer-
dimer interface (along a single protofilament), and protofilament-
protofilament interface (side-to-side between tubulin in two
Figure 5. Unique zinc binding sites on tubulin. Top row - all 64 predicted sites at low stringency (red). Bottom row - top six predicted sites at
high stringency (green). Light grey - a-tubulin, Dark grey - b-tubulin, Blue - Exchangeable GTP/GDP site. Tubulin is rotated in 90u increments moving
from left to right. Scale bar corresponds to 5 nm.
doi:10.1371/journal.pone.0033552.g005
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assembly. Zinc is a divalent positive ion, and likely to affect the
electrostatic surface. Several key changes were observed in the
overall electrostatic profile of tubulin upon addition of zinc (see
Figure 6).
The change in region 1 is due to zinc binding at residues
bCys241, bCys356, and bAsp357, which is near the colchicine-
binding region. The change increases the area’s positive potential.
In normal protofilament-protofilament interactions this positive
region interacts with the negative region of an adjacent dimer. By
increasing the positive potential the interaction strength would be
increased.
The change in region 2 is due to zinc binding at the MT surface
to residues bHis266, bGlu431. Since this region is on the outer
surface of the MT, it is not expected to play a role in normal
protofilament-protofilament interactions. However, it is expected to
strengthen protofilament-protofilament interactions in zinc induce
sheet formations due to the anti-parallel protofilament alignment.
The change in region 3 is due to the zinc ion interacting with
aHis192, aGlu420, and aAsp424, including one of the key
residues involved in zinc-induced tubulin sheet formation. This
large change from a negative potential to a positive potential
occurs on the outer MT surface, and again is not expected to play
a role in normal protofilament-protofilament interactions. How-
ever, as with region 2, it would strengthen protofilament-
protofilament interactions in the zinc-induced sheet formation.
The change at region 4 is due to the combined effects of zinc at
regions 2, 3, and 5. This region normally has a negative potential,
which interacts with a positive region on an adjacent protofilament
to promote assembly. The increase in positive potential along the
interface between a and b tubulin would serve to weaken the
binding between protofilaments.
The change at region 5 is due to zinc binding to residues at
aAsp69, aGlu71 near the non-exchangeable GTP site on a-
tubulin. This region is normally negative, and due to protofilament
shift interacts with a negative region on adjacent dimers. By
changing the region to a positive potential the protofilament-
protofilament interaction would strengthen. However, if both
region 1 and region 5 have increased positive potentials due to zinc
binding, the protofilament-protofilament interaction would be
severely hindered, possibly promoting the transition to the zinc
sheet formation.
The change at region 6 is due to the combined effects of the zinc
at residues bCys241, bCys356, and bAsp357, as well as the zinc at
bHis139. This effect is minor, and not expected to play a significant
role in protofilament-protofilament or dimer-dimer interactions.
The change in region 7 is due to the zinc ion near the
exchangeable GTP binding region binding with bHis139. This
change is minor, and while moving from a negative potential to a
more positive potential, it is not expected to induce any significant
change in dimer-dimer interactions. However, GTP hydrolysis at
this site triggers MT depolymerization, e.g. catastrophes (Figure 1),
so the presence of zinc at this site may stabilize microtubule
assembly by preventing such events.
Presence of zinc at low to moderate levels is thus expected to
increase side-to-side, protofilament-protofilament interactions, sta-
bilizing and promoting MT polymerization, and possibly prevent-
ing depolymerization by GTP hydrolysis (Figure 7). However, at
higher zinc concentrations protofilament interactions would be
hindered, and anti-parallel protofilament orientation would become
preferred, promoting transition to zinc-sheet formations.
As discussed above, AD is known to be associated with
abnormal behavior of MAP-tau. With regard to zinc, concentra-
tions of zinc 10- to 30-fold lower than the normal 100–300 mM
concentrations found in synaptic vesicles have been found to
enhance MAP-tau fibrillization [80]. MAP-tau induces coopera-
tive binding of the chemotherapeutic drug taxol to MTs, and the
repeat motifs of MAP-tau stabilize MTs in a way similar to taxol
indicating the importance of this region to MAP-tau-MT
interactions [81,82]. Hydroxide ions in solution, or interacting
proteins, may react with the predicted zinc-binding site near the
taxol-binding region, which is bound by only two cysteine residues
(Figure 8). The key interacting regions of the repeat motifs of
MAP-tau, which possess a sequence similarity with a region of a-
tubulin that normally occupies the taxol-binding site [83], contain
a histidine residue capable of interacting with zinc. Additionally,
repeat 3 contains an additional histidine within this region.
Beyond the sequence similarity region each of the four repeats
Figure 6. Effect of the top six zinc binding sites on the tubulin electrostatic. Rotation of the tubulin dimer in 90u increments from left to
right. Top row – tubulin without zinc. Bottom row – tubulin with zinc at the top six sites, arrows indicate regions of change. Blue – positive charge,
Red – negative charge, White – electrostatically neutral. Potential map ranges from 21 kT/e to 1 kT/e. Scale bar corresponds to 5 nm.
doi:10.1371/journal.pone.0033552.g006
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in repeat 1, cysteine and aspartic acid in repeat 2, cysteine in
repeat 3, and aspartic acid in repeat 4). This suggests that a zinc
ion in the taxol-binding region may further stabilize MAP-tau
binding to MT. However, the exact structure of and interaction in
these binding regions is unknown.
Kinetic Model of Ab-induced Zinc Dyshomeostasis
Leading to Microtubule Destabilization
Below we develop a simple mathematical model that quantifies
the interplay between zinc absorption by Ab (and a subsequent
aggregation [83] with zinc binding by MTs and its utilization in
tubulin re-incorporation into MTs. An insufficient supply of zinc
Figure 7. Changes in tubulin interactions due to presence of zinc. In the absence of zinc both longitudinal (dimer-dimer) interactions, and
lateral (protofilament-protofilament) interactions, (A) and (B) respectively, behave at baseline (black arrows). Longitudinal interactions are not
affected by zinc. Zinc bound to tubulin (affected areas in green) at region 3 or region 5, (C) and (D) respectively, has increased lateral interactions
(green arrows). Zinc bound to tubulin at region 3 and region 5, (E), have decreased lateral interactions (red arrows).
doi:10.1371/journal.pone.0033552.g007
Figure 8. Zinc interaction with the Taxol binding region. (A) Transparent tubulin dimer surface overlaying a cartoon representation. Green
Spheres - high stringency predicted zinc-binding sites. Orange – Taxol binding pocket. Scale bar 5 nm. (B) Predicted zinc site bound by cysteine 239
and cysteine 354 (yellow) is within 7 A ˚ of serine 234 and proline 358 of the taxol binding pocket characterized by [37]. Scale bar 5 A ˚.
doi:10.1371/journal.pone.0033552.g008
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inside neurons leading to their gradual deterioration.
The model we develop is based on Figure 9 where Ab resides in
the extracellular compartment and satisfies polymerization kinetics
catalyzed by zinc. Due to the six orders of magnitudes in the
difference between the binding affinities of zinc for Ab as
compared to tubulin, it can be safely assumed that only excess
zinc finds its way into the nearby neurons and then into the
polymerizing MTs.
First, we assume the total concentration of b-Amyloid protein
[A] to be a combination of free Ab [Ab] and b-Amyloid Plaque
[bAP]:
½A ~½Ab z½bAP 
½Ab ~½A {½bAP 
ð6:1Þ
Thus,
Ab?
ko bAP ð6:2Þ
where ko is the rate of b-Amyloid oligomerization.
The rate equation describing this reaction is:
d½bAP 
dt
~ko½Ab 
~ko(½A {½bAP )
ð6:3Þ
The solution of this rate equation is given by:
½bAP(t) ~½A (1{e{kot)z½bAP(0) e{kot ð6:4Þ
where [bAP(t)] is the time dependent concentration of b-Amyloid
plaques with [bAP(0)] being the initial concentration of plaques.
This will reach a saturation point when the entire concentration of
amyloid protein becomes oligomerized into plaques. If zinc has
not been completely depleted beyond this saturation point
however, the free concentration of zinc z(t), is given by,
½z(t) ~½Z(t) {n½bAP(t) ð 6:5Þ
where n is the number of zinc binding sites on b-Amyloid plaques,
and [Z(t)] is the time dependent zinc influx concentration.
Taking the total concentration of tubulin protein [P] to be a
combination of free tubulin protein [Tu] and MTs [MT], i.e.
½P ~½Tu z½MT 
½Tu ~½P {½MT 
ð6:6Þ
we incorporate in the model the fact that zinc increases the
polymerization rate of free tubulin into microtubules, kp, thus:
Tu<
~ k kp
kd
MT ð6:7Þ
Figure 9. Schematic representation of the multi-compartment model for the kinetic equations governing the dynamics of zinc
binding to Ab and MTs. (A) Normal brain, zinc crosses the membrane and promotes MT polymerization. (B) AD brain, Ab sequesters zinc
promoting plaque formation, while MT polymerization is compromised resulting in a loss of MT.
doi:10.1371/journal.pone.0033552.g009
h
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~ k kp~kpzkz½z(t) ð 6:8Þ
and kz is a constant describing how zinc increases tubulin
polymerization, [z(t)] is the time dependent zinc concentration
after sequestration by Ab, and kd is the rate at which MTs
depolymerize into free tubulin. The rate equation describing this
reaction is:
d½MT 
dt
~~ k kp½Tu {kd½MT 
~(kpzkz½z(t) )
(½P {½MT ){kd½MT 
d½MT 
dt
z(kpzkz½z(t) zkd)½MT ~(kpzkz½z(t) )½P 
ð6:9Þ
The solution of this differential equation can be obtained
numerically to give the MT concentration as a function of time
[MT(t)].
Taking approximately 10
9 tubulin dimers polymerized in MTs
per neuron, 10
11 neurons per brain and an average brain volume
of 1.3 L gives the average concentration of polymerized tubulin
protein in the brain as 130 mM. However, in the neuron this may
be ,3 times higher since glial cells, possessing a MT density much
less than neurons, are considered to comprise 50% of the brain.
The remaining portion is composed of both neurons and other
necessary structures such as ventricles, blood vessels etc. This also
does not account for the roughly 20 mM free tubulin dimers in the
cytosol. Here, for the purpose of model calculations, we assume
the total tubulin protein concentration [P] to be 400 mM.
The MT depolymerization rate constant kd can range between
7 and 89 s
21 depending on the buffer conditions [84]. Here, we
assume a reasonable value of 70 s
21. The polymerization rate
constant kp at physiological temperature is given as 9 mM
21 s
21
and depends on the concentration of free GTP-bound tubulin
[84]. Taking the concentration of free GTP-bound tubulin to be
10 mM, slightly above the critical concentration, gives kp=90s
21.
With these parameter values and a reasonable zinc-dependent
rate constant, kz,o f1 5mM2
1 s
21, the MT concentration in the
absence of zinc is 60% of the value when the zinc concentration is
30 mM (3 times the value of free GTP-bound tubulin). This is
comparable to experiment that shows in the absence of zinc the
MT concentration is 50% of the concentration when the zinc to
tubulin ratio is just below 3:1, the condition for sheet forma-
tion [48]. The long time limit microtubule concentration as a
function of zinc concentration, for these parameters, is shown in
Figure 10 A.
In the absence of b-amyloid, the polymerized MT concentra-
tion remains constant (Figure 10 B). The inclusion of b-amyloid
predicts sequestration of the zinc available for tubulin polymer-
ization leading to an overall loss of MTs. In the case where the
concentration of b-amyloid is low, free zinc remains available to
polymerizing tubulin protein (Figure 10 C). If the concentration of
b-amyloid is high, then all zinc is sequestered, and the MT
concentration drops to its lowest possible value (Figure 10 D). For
the parameters given, and a b-amyloid oligomerization rate
constant of 2.465(10
24)s
21 [85], as little as 25 mM of free b-
amyloid per neuron is capable of reducing the overall MT
concentration to 64% of its original value, giving a loss of 36%
(Figure 10 D). By increasing the depolymerization rate constant,
kd,t o8 9s
21, this value can be brought to a 40% loss.
Experimental findings suggest an overall reduction in MT
density in AD neurons of 50–55% [2,86]. Comparable loss can be
obtained by increasing the zinc dependent rate constant, kz,t o
100 mM
21 s
21, but the exact physiological effect of zinc on tubulin
polymerization remains unclear. While these values are compa-
rable the discrepancies do indicate missing factors in the model.
This is expected as MT assembly and b-amyloid oligomerization
dynamics are kinetically complex, and all factors are not
accounted for in this first approximation. However, the general
qualitative features of this model indicate that zinc deficiency
induced by b-amyloid deposition can result in an overall reduction
in MT number independent of PHF formation.
Metallomic Imaging Mass Spectrometry (MIMS Mapping)
of Elemental Zinc Distribution in the Brain of Aged
Tg2576 AD Transgenic Mice Compared to Wild Type
Controls
Tg2576 mice over-express human Ab and age-dependently
exhibit Ab neuropathology and associated neurophysiological
deficits that model many aspects of the human clinical disease.
Representative
66Zn MIMS maps of brains from 22-month-old
Tg2576 AD mice and age-matched littermate controls reveal
profound AD-specific pathogenic redistribution of zinc in the
brains of Tg2576 mice compared to age-matched littermate
controls (Figure 11). MIMS mapping revealed AD-linked zinc
redistribution and localized pathogenic zinc accumulation within
discrete zinc-enriched brain regions (i.e., hippocampus, dentate
gyrus, subiculum, and cortical layer II) that are important for
memory processing, and especially vulnerable to amyloid-Ab
deposition and AD neuropathology. These data show that zinc
dyshomeostasis correlates anatomically with brain areas involved
in AD neuropathology, and cognitive dysfunction.
Discussion
A confirmed diagnosis of AD requires abundant levels of
extracellular amyloid plaques composed of Ab, and intracellular
NFTs composed of hyper-phosphorylated tau. While all four of the
well-established genes for AD are associated with excessive
accumulation of Ab, NFTs are required for driving cognitive
impairment. The mechanism linking excessive b-amyloid to tangle
pathology, and the specific mechanism by which NFT result in
cognitive impairment remains unknown. Here, we suggest that
sequestration of zinc by b-amyloid deposits (Ab oligomers and
plaques) leads to reduced intra-neuronal zinc levels, and in some
cases excess zinc, in neighboring neurons. Low zinc, or excessive
zinc, then destabilizes microtubules, leading to NFT and cognitive
impairment.
To investigate the hypothesis, we:
1) Employed molecular modeling of zinc binding to tubulin, the
component protein of microtubules. We find that adequate,
but not excessive levels of zinc strengthen side-to-side
electrostatic attraction, promoting microtubule lattice stabil-
ity, and that high levels of zinc promote aberrant interactions.
2) Present a kinetic model of Ab-induced zinc dyshomeostasis
leading to microtubule destabilization.
3) Demonstrate element-specific, anatomically localized zinc
dyshomeostasis in specific brain regions of aged Tg2576 AD
transgenic mice compared to wild-type littermate controls.
We conclude with an overall hypothesis of AD pathogenesis in
which excessive levels of extracellular Ab in the form of oligomers
and amyloid plaques result in low intraneuronal zinc levels. This in
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electrostatic interactions between tubulins (and thus reduced
protofilament-to-protofilament interactions). Insufficient zinc
may also trigger GTP hydrolysis and MT ‘catastrophes’, which
then induce NFT formation and cognitive impairment. Excess
zinc also destabilizes MTs thorough aberrant tubulin interactions.
This novel hypothesis links b-amyloid pathology to intra-neuronal
lesions and cognitive impairment via microtubules.
This hypothesis is consistent with recent experimental evidence.
Grabrucker et al. investigate the effects of low/insufficient
intracellular zinc due to Ab sequestration [87]. They found
insufficient zinc leads to a reduction in synapse density, and
ProSAP2/Shank 3 and Shank 1 protein levels in the postsynaptic
density independent from alterations on the transcription level.
However, the effect of zinc levels on NFT formation and MT
destabilization is not considered. These findings may be the result
of hindered MT-based transport of proteins, and a general feature
of neurons with insufficient or excess zinc. Kim et al. consider the
AD-related effects of excess zinc [88]. They conclude that zinc
induces tau Ser214 phosphorylation through the Ras-Raf/
mitogen-activated protein kinase kinase/extracellular signal-regu-
lated kinase (ERK) pathway, which interferes with microtubule
polymerization. However, as we have discussed, excess intracel-
lular zinc may induce aberrant MT formations leading to an
increase in free tau vulnerable to hyperphosphorylation, such as by
the ERK pathway. This would indeed explain both the increase in
tau phosphorylation, and the MT destabilization.
It has been suggested that the relation between Ab and NFTs is
based in mTOR-dependent signaling [89], with tau phosphory-
lation regulated by PI3K/mTOR signaling [90]. Ab accumulation
has been shown to increase mTOR signaling [91], suggesting that
Ab may facilitate tau pathology through the mTOR pathway.
However, studies at the Karolinska Institutet suggests that both Ab
and increased extracellular zinc can activate mTOR-dependent
signaling, resulting in an increase of tau synthesis and phosphor-
ylation [89,92–94]. In fact, the increase in phosphorylated
p70S6K levels in differentiated SH-SY5Y cells treated with
Ab42 [95] is approximately consistent with the increase seen in
undifferentiated SH-SY5Y cells treated with 100 mM zinc [94].
Further, the mTOR pathway is activated by microtubule damage
[96], so mTOR activation may follow Ab zinc sequestration and
microtubule instability.
The hypothesis suggests that effective treatment and prevention
of AD could be achieved by approaches aimed at microtubule
function and stability. Pharmacologically, this could be a
compound that could competitively remove zinc away from Ab,
and redistribute it back to neurons. The 8-hydroxyquinolone and
zinc ionophore, PBT2 (Prana Biotechnology) has been reported to
Figure 10. Kinetic model of zinc dyshomeostasis. (A) MT concentration as a function of zinc concentration in the long time limit for kp=90s
21,
kd=70s
21, and [P]=400 mM. (B)–(D) Kinetics of b-Amyloid zinc depletion on Microtubule Polymerization. Microtubule (red), b-Amyloid (blue), free
zinc after b-Amyloid sequestration (yellow). Parameters: kp=90s
21,k d=70s
21,k z=15mM
21 s
21,k o=2.465(10
24)s
21, [P]=400 mM, Z(0)=20 mM. b-
Amyloid protein concentrations for the three cases are, (B) [A]=0 mM, (C) [A]=15 mM, and (D) [A]=25 mM.
doi:10.1371/journal.pone.0033552.g010
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cognition in AD mouse models [97]. Additionally, in a phase 2
clinical trial PBT2 rapidly led to significant cognitive improvement
in AD patients [98]. With regard to mechanism of action, PBT2
enters the brain and is then attracted to the extracellular pool of
zinc that is in a dissociable equilibrium with Ab, e.g., in senile
plaques and oligomers. PBT2 would then form a ternary complex
with zinc and Ab. The affinity of PBT2 for zinc (10
212 to 10
213)i s
several orders of magnitude stronger than that of Ab. Thus, PBT2
is able to strip zinc away from Ab leading to reduced aggregation,
dissolution of Ab oligomers (that have not been covalently cross-
linked). The drug-zinc complex can then enter the cell leading to
redistribution of zinc that was previously trapped by Ab deposits,
e.g. synaptic oligomers and amyloid plaques. PBT2 was able to
prevent Ab oligomer-induced inhibition of LTP and restore
dendritic spine density in transgenic mice. While this protective
effect could be partially due to the prevention and dissolution of
Ab oligomers, it is also possible that the liberation and
redistribution of zinc, which was trapped in Ab aggregates, was
responsible. In support of the latter, Adlard et al. [99] showed that
knock out of the zinc transporter, ZnT3, responsible for releasing
zinc into the synapse led to impaired LTP and cognitive deficits
similar to those observed in AD transgenic mice. Thus, it would be
interesting to test whether a zinc ionophore, like PBT2, might also
be able to prevent NFT formation in the presence of excess Ab
oligomer and b-amyloid deposits, by redistributing zinc that was
previously sequestered by b-amyloid into neurons and onto MT
according to the hypothesis proposed in this paper. Redistribution
of zinc to MTs may not only prevent tauopathy and NFT
formation, but, in a more general context, also ameliorate
cognition based on the proposed direct role of MTs in information
processing.
In addition to pharmacological intervention, another therapeu-
tic approach to AD suggested by our hypothesis could include
energy/field therapies aimed at microtubule polymerization and
integrity. Transcranial magnetic, electric and ultrasound therapies
are noninvasive techniques being tested for treatment of
psychiatric and neurological disorders. Transcranial magnetic
stimulation (TMS) has been used for treatment of depression
[100], and transcranial electrical stimulation (TES) has been
shown to improve memory [101]. Transcranial ultrasound (TUS)
is application of mechanical vibrations to the scalp, e.g. in the
temporal region, in the range between 20,000 Hz and 30
megahertz, shown to have electrophysiological and behavioral
effects in animals [102,103]. Microtubules have been shown to
have resonances precisely in the range of TUS (e.g. 12 kHz to
30 MHz [104]). Thus, TUS may promote microtubule activity,
and is a potential therapeutic tool for the treatment of AD.
In summary, we propose a novel hypothesis linking b-amyloid
and tangle pathologies in AD. The sequestration of zinc by b-
amyloid deposits (Ab oligomers and plaques) not only drives
aggregation of Ab but leads to local zinc dyshomeostasis and
Figure 11. Elemental zinc (
66Zn) dyshomeostasis in aged Tg2576 AD transgenic mice compared to wild-type littermate controls. (A)
Low-resolution metallomic imaging mass spectrometrometry (MIMS) intensity profile of
66Zn in a 22-month-old wild-type mouse brain in sagittal
section. White box shows detail area of hippocampus, parahippocampal cortex, and major white matter tracts (i.e., corpus callosum, hippocampal
fimbria) in panels C and D. An identical zinc distribution profile was observed in the
70Zn channel simultaneously obtained during analysis of the
same brain section (not shown). (B) Low-resolution metallomic imaging mass spectrometrometry (MIMS) profile of
63Cu simultaneously acquired from
the same Tg2576 brain section. Note element-specific distribution pattern of
63Cu compared to
66Zn. (C) High-resolution
66Zn MIMS profile of a 22-
month-old wild-type mouse hippocampus, adjacent cortex, and parahippocampal fiber tracts. Note prominent laminar distribution of zinc in cortical
layer II and hippocampus. (D) High-resolution
66Zn MIMS profile of a 22-month-old Tg2576 transgenic mouse brain. Abnormal zinc accumulation is
present in all cortical layers, including deep and superficial cortex (black and white arrows, respectively) as well as hippocampus (white hashed
ellipse). Pathogenic zinc deposits are also present in white matter (hashed black circles). Regional MIMS profiles of
66Zn (66Zn, 65.926 amu, 27.9%
abundance) were confirmed by simultaneous profiling of
70Zn (69.925 amu, abundance 0.6%; 25 mm resolution) in each brain section. Metallomic
imaging mass spectrometry analyses were conducted at the Center for Biometals & Metallomics, Boston University School of Medicine, Boston, MA.
doi:10.1371/journal.pone.0033552.g011
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predicted to engender reduced and/or excess intra-neuronal zinc
levels. Employing molecular modeling of zinc binding to
microtubules (MTs) versus Ab, we demonstrate how insufficient
and/or excessive intra-neuronal zinc levels could destabilize
microtubules, freeing tau proteins to aggregate in paired helical
filament and NFT, leading to neurodegeneration and cognitive
impairment. Experimental testing in cell- and animal-based
models of AD will be necessary to provide physical evidence
supporting this zinc dyshomeostasis hypothesis of AD linking b-
amyloid and NFT pathologies.
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